MedTrace Logo

REmotely Supervised Exercise Therapy Trial 2

NCT04925219 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-01-12

No results posted yet for this study

Summary

Supervised exercise for intermittent claudication is a first line therapy for peripheral arterial disease, as recommended by the National Institute for Health and Clinical Excellence and the European Society for Vascular Surgery. However 2/3 of British trusts cannot implement this due to gym availability, costs, travel time and the requirement for social distancing.

During the COVID-19 lockdown the investigators successfully performed a feasibility study for remotely supervised exercise using an electronic walking log and fortnightly video calls with a physiotherapist.

RESET2 aims to compare the benefits of and adherence to remotely supervised exercise with self-directed exercise to absolute walking distance.

Conditions

  • Claudication, Intermittent
  • Peripheral Arterial Disease

Interventions

BEHAVIORAL

Remotely supervised exercise programme

Electronic walking log Fortnightly video/telephone calls with physiotherapist

BEHAVIORAL

Self-directed exercise

Electronic walking log and instructions to exercise 4 times per week.

Sponsors & Collaborators

  • Mid and South Essex NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Ankur Thapar, PhD · Mid and South Essex Hospitals NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04925219 on ClinicalTrials.gov